Latest Strategy News

Blaze Minerals has completed a 443-metre trenching campaign at its Krokodil Prospect in Botswana, confirming in-situ copper, lead, and zinc mineralisation with notable spot XRF readings. Laboratory assay results are expected in 6-8 weeks as the company plans further soil sampling to extend the target zone.

Norwood Systems has landed a paid pilot trial with a major UK telecom to showcase its OpenSpan AI orchestration and CogVoice applications, marking a key step in its international expansion.

Patagonia Lithium’s Well 7 at Formentera delivered a lithium assay of 270ppm at 282m, close to the project average, alongside encouraging porosity and specific yield results that underpin production potential. Drilling will now shift to the Cilon concession, targeting a high-grade lithium zone.

Rokeby Resources appoints Richard Beazley as Managing Director and Tim Pallas as Chairman, signalling a strategic leadership overhaul to support the acquisition and development of the high-grade Omeo Gold Project in Victoria.

Critica Limited is progressing its Jupiter and Mt Lindsay projects with key resource updates, metallurgical breakthroughs, and strategic partnerships, targeting Scoping Study completion in Q3 2026.

Zinc of Ireland (ASX: ZMI) has finalised its acquisition of Meclex, securing two hydrometallurgical technologies aimed at disrupting zinc and lead processing with low-emission methods. Backed by a fresh A$5.5 million placement, ZMI is accelerating pilot plant development and exploration at its Kildare project.

Neurizon Therapeutics has secured a critical five-year supply agreement with Elanco Animal Health for GMP-grade monepantel, underpinning the commercialisation readiness of its lead ALS drug candidate NUZ-001.

Argent Minerals appoints mining veteran Mike McKevitt as CEO to spearhead advancement of its flagship Kempfield Silver Project and evaluate growth across gold and copper assets.

Great Divide Mining Ltd (ASX: GDM) has received its first cash payment of USD 78,480.35 from gold concentrate sales at its Challenger Gold Mine, marking a key milestone in its transition from explorer to producer within three years of listing.

Hillgrove Resources has delivered consistent high-grade copper-gold drill results from its Emily Star underground project, underpinning a pivotal Stage 2 investment decision later this year.

Island Pharmaceuticals has won a key regulatory boost as the US FDA granted Orphan Drug Designation to Galidesivir for post-exposure prophylaxis of Marburg virus disease, enhancing its commercial and development prospects.

Dateline Resources has pinpointed three priority zones for heavy rare earth exploration at its Music Valley project in California, following a detailed helicopter-borne geophysical survey that revealed structurally complex areas with elevated thorium signatures.